Explore >> Select a destination
|
You are here 
|
www.cardiobrief.org | ||
| | | | |
www.detroitnews.com
|
|
| | | | | Novo Nordisk A/S's blockbuster diabetes drug Ozempic cut patients' risk of dying in a kidney-disease study, the latest research pointing to the medicine's usefulness in a constellation of disorders. | |
| | | | |
inhumanexperiment.blogspot.com
|
|
| | | | | Experiments to live longer and healthier | |
| | | | |
fabgrandma.com
|
|
| | | | | Please Activate Javascript The SPIRE program is looking for people who are taking a cholesterol lowering medication but still have high cholesterol. If you qualify, you might be interested in participating in a research study. This study evaluates the PCSK9 inhibitor, Bococizumab compared to placebo, in reducing the occurrence of major cardiovascular events, including cardiovascular | |
| | | | |
news.keckmedicine.org
|
|
| | | Newsroom Keck Medicine of USC | ||
